Drugs for Systemic Autoimmune disease Flashcards

1
Q

what’s the point of being COX-2 selective

A

there are two cyclooxyrgenase enzymes
COX-1: physiological function in the gut and kidney
COX-2: induced in inflammation and repair

by being selective for COX-2 you avoid GI side effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

NSAIDs that are not COX-2 selective

A

ibuprofen, diclofenac, naproxen, ketoprofen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

NSAIDs that are COX-2 selective

A

meloxicam, celecoxib, etoricoxib

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

cardiovascular toxicity of NSAIDs

A

increases rates of vascular events, hypertension and heart failure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

do non-selective or selective NSAIDs increase cardiovascular risk

A

both

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

how corticosteroids are used

A

usually prednisolone or prednisone
used for things like RA, SLE, cranial arteritis, polymyalgia rheumatica etc.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

how corticosteroids are used

A

usually prednisolone or prednisone
used for things like RA, SLE, cranial arteritis, polymyalgia rheumatica etc.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

problems with corticosteroids

A

obesity, muscle wasting
osteoporosis, bone loss, minimal trauma fractures
increased risk fo sepsis (immunosuppressive)
raised BSL
hypertension
increased rate of vascular events - myocardial infarction and stroke

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

mechanism of action of antimalarials

A

antilysosomal
interferes with antigen processing, decreased stimulation of T cells, decreased cytokine release

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what are antimalarials used for to treat systemic autoimmune disease

A

used as single agent in RA and Lupus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

mechanism of action of sulphasalazine

A

binding of sulphapyridine molecule with acetylsalicylic acid via an azo bond
inti inflammatory, action on folate metabolising enzymes, action on inhibiting neutrophils

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

toxicity of sulphasalazine

A

GIT, rash (may be severe), headache, pancytopenia, hepatitis,

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

pharmacology of methotrexate

A

forms monoglutamates and poly glutamates
higher blood levels in renal impairment
can be used in combination with NSAIDs, probenecid imparts its clearance
immunomodulatory effects in RA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

toxicity of methotrexate

A

nausea, vomiting, diarrhoea
general fatigue and higher function problems, concentration and memory
bone marrow suppression, hepatic toxicity (particularly with alcohol) and mouth ulceration, hair loss
pneumonitis
can reduce folic acid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

monitoring for sulphasalazine

A

FBC, LFTs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

monitoring for methotrexate

A

FBCs, LFTs, AST, U&Es monthly
reduce 2-3 monthly

17
Q

leflunomide is a

A

prodrug

18
Q

pharmacology of leflunamide

A

blocks pyrimidine synthesis and interferes with T cell function
blocks dihydroorotate dehydrogenase

19
Q

toxicity for leflunomide

A

GIT, hypertension, peripheral neuropathy, rash, hepatic, bone marrow, pneumonitis

20
Q

monitoring for leflunomide

A

FBS, LFTs

21
Q

pharmacology of azathioprine

A

purine analogue
blocks HGPRT synthase
reduces purine synthesis
lymphocytes can’t proliferate (B and T cells)

22
Q

problem with Azathioprine

A

some people have functional genetic polymorphisms affecting the TPMT enzymes responsible for metabolism.
low activity of the TPMT enzyme causes metabolites of 6-MP (6TGN) to accumulate.
this causes bone marrow toxicity

23
Q

azathioprine is metabolised into

A

6-MP

24
Q

low TPMT causes what to accumulate

A

6TGN

25
Q

6TGN causes

A

bone marrow toxicity

26
Q

toxicity of azathioprine

A

GIT
increased rate of infection and malignancies
bone marrow and hepatic toxicity

27
Q

cyclosporin A pharmacology

A

fungal metabolite
lipophilic cyclic peptide
inhibits T cell proliferation

28
Q

mycophenylate mofetil

A

calcineurin inhibitor
used for lupus, polymyositis, vasculitis

29
Q

tacrolimus is used for

A

used in SLE

30
Q

cyclophosphamide

A

alkylating agent
severe lupus, scleroderma lung

31
Q

list some Anti-TNF inhibitors

A

etanercept, alalimumab, infliximab, certolizumab, pegol, golimumab

32
Q

toxicity of anti-TNF inhibitors

A

usual and atypical infections
(also very expensive)

33
Q

anti-TNF inhibitors are contraindicated in

A

TB, skin cancers, heart failure contraindicated and in demyelinating conditions
can produce autoimmune conditions

34
Q

anti-T cell inhibitor - abatacept

A

blocks interaction with CD28
blocks T cell costimulation and activation
combine with methotrexate

35
Q

anti L6 inhibitor: tocilizumab

A

use without methotrexate
blocks IL-6, suppresses synovitis and joint damage and the acute phase response

36
Q

what to monitor for anti L6 inhibitor tocilizumab

A

monitor FBC, increased rate of common and atypical infections

37
Q

anti B cell inhibitor: rituximab

A

significantly reduces B cell numbers and immunoglobulin levels
combine with methotrexate
can be repeated every 6-12 months

38
Q

new biologics and small molecules

A

anti IL17 and anti IL22 molecules - can be combined
JAK kinase inhibitor

39
Q

apremilast

A

phosphodiesterase inhibitor for psoriatic arthritis